CNR1 and granular corneal dystrophy type II: Mast cell downregulation, alongside a decrease in IL-4 levels, was also reported in an in vivo model for ACD induced with oxazolone on Balb/c and hairless mice that were treated with a topical synthetic CB1 agonist named α-oleoyl oleylamine serinol (α-OOS) [179].